Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001806952-25-000008
Filing Date
2025-08-12
Accepted
2025-08-12 16:13:47
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20250630.htm   iXBRL 10-Q 1538998
2 EX-4.1 lyel-20250630x10qxexx41.htm EX-4.1 54648
3 EX-10.1 lyel-20250630x10qxexx101.htm EX-10.1 57106
4 EX-10.2 lyel-20250630x10qxexx102.htm EX-10.2 39400
5 EX-31.1 lyel-20250630x10qxexx311.htm EX-31.1 10485
6 EX-31.2 lyel-20250630x10qxexx312.htm EX-31.2 10455
7 EX-32.1 lyel-20250630x10qxexx321.htm EX-32.1 7391
13 exhibit41certificatea.jpg GRAPHIC 111094
14 image_0a.jpg GRAPHIC 36893
15 image_1a.jpg GRAPHIC 363
16 lyel-20250630_g1.jpg GRAPHIC 129213
17 lyel-20250630_g2.jpg GRAPHIC 110087
18 lyel-20250630_g3.jpg GRAPHIC 43538
19 lyel-20250630_g4.jpg GRAPHIC 68645
20 lyel-20250630_g5.jpg GRAPHIC 156238
21 lyel-20250630_g6.jpg GRAPHIC 176747
22 lyel-20250630_g7.jpg GRAPHIC 215761
  Complete submission text file 0001806952-25-000008.txt   10124159

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20250630.xsd EX-101.SCH 50311
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20250630_cal.xml EX-101.CAL 59725
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20250630_def.xml EX-101.DEF 266224
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20250630_lab.xml EX-101.LAB 650947
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20250630_pre.xml EX-101.PRE 464557
88 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20250630_htm.xml XML 1002470
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 251206848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)